Cargando…
Deciphering cell lineage specification of human lung adenocarcinoma with single-cell RNA sequencing
Lung adenocarcinomas (LUAD) arise from precancerous lesions such as atypical adenomatous hyperplasia, which progress into adenocarcinoma in situ and minimally invasive adenocarcinoma, then finally into invasive adenocarcinoma. The cellular heterogeneity and molecular events underlying this stepwise...
Autores principales: | Wang, Zhoufeng, Li, Zhe, Zhou, Kun, Wang, Chengdi, Jiang, Lili, Zhang, Li, Yang, Ying, Luo, Wenxin, Qiao, Wenliang, Wang, Gang, Ni, Yinyun, Dai, Shuiping, Guo, Tingting, Ji, Guiyi, Xu, Minjie, Liu, Yiying, Su, Zhixi, Che, Guowei, Li, Weimin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586023/ https://www.ncbi.nlm.nih.gov/pubmed/34764257 http://dx.doi.org/10.1038/s41467-021-26770-2 |
Ejemplares similares
-
The heterogeneous immune landscape between lung adenocarcinoma and squamous carcinoma revealed by single-cell RNA sequencing
por: Wang, Chengdi, et al.
Publicado: (2022) -
Single-Cell Transcriptomics of Immune Cells Reveal Diversity and Exhaustion Signatures in Non-Small-Cell Lung Cancer
por: Zhao, Ying, et al.
Publicado: (2022) -
COVID-19 in early 2021: current status and looking forward
por: Wang, Chengdi, et al.
Publicado: (2021) -
Distinct immune microenvironment of lung adenocarcinoma in never-smokers from smokers
por: Luo, Wenxin, et al.
Publicado: (2023) -
The landscape of immune checkpoint inhibitor plus chemotherapy versus immunotherapy for advanced non‐small‐cell lung cancer: A systematic review and meta‐analysis
por: Wang, Chengdi, et al.
Publicado: (2019)